Mira Sofie W.
- Country
- Austria
- Department
- Department for Internal Medicine, Hematology and Internal Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 90 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in advanced therapeutic approaches for estrogen receptor-positive (ER+) and HER2-negative breast cancer. Their research encompasses treatment strategies for patients with metastatic breast cancer, particularly focusing on cases that have progressed following standard treatments.
- Advanced breast cancer therapies
- Hormone receptor-positive disease management
- Metastatic disease treatment
Endocrine Therapy
The investigator's work centers on developing treatment options for patients who have received prior endocrine therapy. Their research involves evaluating novel therapeutic approaches for cases where conventional hormone treatments require alternative strategies.
- Post-endocrine therapy treatment
- Novel therapeutic compounds
- Treatment resistance management
Targeted Therapies
The investigator explores innovative treatment approaches for patients who have undergone CDK 4/6 inhibitor therapy. Their research focuses on developing and evaluating new therapeutic options for those who require subsequent treatment lines.
- Post-CDK 4/6 inhibitor strategies
- Novel drug development
- Treatment sequencing approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.